[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$6share
Crypto project $6share sees community excitement. Market volatility causes price fluctuations.
About $6share
A cryptocurrency project.
Insights #
- $6share engagements is up XXXXX% from the previous week.
Engagements: XXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
1 Week: XXXXXX +7,241%
1 Month: XXXXX -XX%
1-Year High: XXXXX on 2025-07-14
1-Year Low: X on 2025-05-21
| Social Network | X |
|---|---|
| Engagements | XXX |
Mentions: X #
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
1 Week: X -XX%
1 Month: X no change
1-Year High: X on 2025-08-14
1-Year Low: X on 2025-05-03
| Social Network | X |
|---|---|
| Mentions | XX |
Creators: X #
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $6share in the last XX hours which is down XX% from X in the previous XX hours
Daily Average: X
1 Week: X -XX%
1 Month: X no change
1-Year High: X on 2025-08-14
1-Year Low: X on 2025-05-03
The most influential creators that mention $6share in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BiopharmIQ | X | XXXXXX | X | XXX |
Sentiment: XXX% #
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
1 Month: XXX% no change
1-Year High: XXX% on 2025-07-15
1-Year Low: XX% on 2025-07-24
Most Supportive Themes
- Community Enthusiasm: (65%) Positive sentiment regarding project developments and future prospects.
Most Critical Themes
- Market Volatility: (35%) Concerns about price fluctuations and market uncertainty.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXX | XX% | XX | X% | X | X% |
| Total | XXX | XX% | XX | X% | X | X% |
Top assets mentioned In the posts about $6share in the last XX hours
Akero Therapeutics, Inc. Common Stock (AKRO) Novo-Nordisk (NVO) Akropolis (AKRO) PayPal Holdings Inc (PYPL) Bit Digital, Inc. (BTBT) Bit Digital, Inc. (BTBT) Eos Energy Enterprises, Inc. (EOSE) DAOLaunch (DAL) Delta Air Lines, Inc. (DAL)
Top topics mentioned In the posts about $6share in the last XX hours
akro akero therapeutics inc, $novcde, $nvo, stocks healthcare, $akro, $54share, $52b, novo, $47b, $pypl, stocks financial services, $700k, $5m, fell, bit digital, stocks bitcoin treasuries, stocks crypto treasuries, stocks bitcoin miners, $btbt, $telo, acquisition, $ngne, $cdtx, $etnb, $eose, stocks energy, $15share, $dal, dal delta air lines, coins defi, coins dao, stocks industrials, $psnl
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$ETNB competitor developing a MASH treatment $AKRO was just acquired by $NVO. Big pharma is clearly betting heavily on these drugs. Theres also an interesting CVR component attached to the AKRO deal. The offer is for $54/share in cash + $6/share in CVR and the stock currently trades at $54.08/share. The CVR payout is tied to the cirrhosis indication approval as well but with much stronger upside than in the case of ETNB. I havent looked into this in detail yet but its worth checking out"
X Link @InvestSpecial 2025-10-10T13:39Z 31K followers, 5749 engagements
"Now heres the juicy part 🧃 $BTBT trades at least XX% below asset value $XXXX for $X in ETH + AI. If sentiment flips $6/share short-term isnt out of reach. Long-term upside is huge when $ETH and AI take off"
X Link @AthleteInvests 2025-10-10T07:09Z 1767 followers, XXX engagements
"💊 $NVO will acquire Akero Therapeutics for up to $5.2B paying $54/share in cash plus $6/share if its liver drug efruxifermin wins U.S. approval by 2031. Its Novo Nordisks first big move under new CEO Mike Doustdar to expand beyond obesity and diabetes"
X Link @oninvest_tech 2025-10-10T03:37Z XXX followers, XXX engagements
"Novo Nordisk to acquire Akero Therapeutics $AKRO for up to $5.2B. Structured with an upfront payment of $4.7B in cash ($54/share) a XX% premium to $AKRO 30-day VWAP. Also includes a $6/share CVR dependent upon full U.S. regulatory approval of efruxifermin (EFX) by June XX 2031"
X Link @ForFairnessSake 2025-10-09T20:57Z XX followers, XX engagements